You are here

  • Home
  • Archive
  • Volume 12, Issue 8
  • Isolated adrenocorticotropic hormone (ACTH) deficiency and Guillain-Barré syndrome occurring in a patient treated with nivolumab

Article info

Article menu
Download PDFPDF
Unexpected outcome (positive or negative) including adverse drug reactions
CASE REPORT
Isolated adrenocorticotropic hormone (ACTH) deficiency and Guillain-Barré syndrome occurring in a patient treated with nivolumab

Authors

  1. Correspondence to Dr Emmanuel Seront, Emmanuel.seront{at}jolimont.be
View Full Text

Citation

Pierrard J, Petit B, Lejeune S, et al
Isolated adrenocorticotropic hormone (ACTH) deficiency and Guillain-Barré syndrome occurring in a patient treated with nivolumab
BMJ Case Reports CP 2019;12:e230848.

Publication history

  • Accepted July 27, 2019
  • First published August 21, 2019.
Online issue publication 
January 25, 2023

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.